CHLOE EQ’s automated capabilities provide embryologists with previously unachievable data
The company will be presenting its innovation at this month's congress alongside other start-ups in the menopause space
Prestigious international annual awards programme recognises CHLOE EQ for bringing transparency to IVF process
CRGH Insight will utilise Fairtility’s explainable AI for embryo quality analysis, offering transparency to IVF professionals and patients
The company’s currently ongoing Phase IIb pre-pivotal clinical study assesses the safety and efficacy of the IUB™ SEAD
Velocity of execution and acceleration of impact characterise this UK female-founded healthtech start-up. From building a better working world as former director at EY running their...
The femtech industry is not only focused on product development but also on addressing the gender gap in healthcare
The company works with women who participate on a volunteer basis to share their lived experience of menopause
Future Fertility received CE Mark approval for its oocyte assessment software in August and continues to steadily grow its presence across Europe
On January 24, the UK government rejected recommendations from the Women and Equalities Committee to trial menopause leave pilots. It also dismissed recommendations to make menopause...
